Orlando, FL (PRWEB) October 16, 2012
The British Medical Journal last October published a study from the University of Copenhagen which highlighted Yaz side effects, linking the hormone in the birth control drugs Yaz and Yasmine to blood clots.
On October 27, 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" showing drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
Bloomberg News reported on July 31st that Bayer, the maker of Yaz, has begun settling Yaz lawsuits. Now, Injury Lawyer News has reported on September 15, 2012 that those settlements could cost Bayer as much as $1.2 billion.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.
On May 31, 2012, the Institute for Safe Medicine Practices reported that Yaz and Yasmin ranked second highest in 2011 for the number of complications reported to the FDA.
Due to the number of patients who filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the cases. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.
Bloomberg News reported on July 31st that Bayer has resolved as many as 1900 Yaz settlements so far at an average of around $212,000 per case. They have also reserved up to $610 million to settle more of the cases, but indicated they are only settling those related to blood clots.
In The Madison Record on July 11, 2012, special court master Stephen Saltzburg, who is overseeing the negotiations, estimated Yaz lawsuit settlements could be concluded within a year.
The news of Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify. Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.
The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.